• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
The national review of asthma deaths: what did we learn and what needs to change?全国哮喘死亡情况回顾:我们学到了什么,需要做出哪些改变?
Breathe (Sheff). 2015 Mar;11(1):14-24. doi: 10.1183/20734735.008914.
2
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
3
An imperfect "PAST" Lessons learned from the National Review of Asthma Deaths (NRAD) UK.不完美的“过去”:从英国哮喘死亡全国审查(NRAD)中吸取的教训
Respir Res. 2016 Jul 19;17(1):87. doi: 10.1186/s12931-016-0393-9.
4
The Confidential Inquiry into premature deaths of people with intellectual disabilities in the UK: a population-based study.英国智力残疾人群过早死亡机密调查:基于人群的研究。
Lancet. 2014 Mar 8;383(9920):889-95. doi: 10.1016/S0140-6736(13)62026-7. Epub 2013 Dec 11.
5
[Standard technical specifications for methacholine chloride (Methacholine) bronchial challenge test (2023)].[氯化乙酰甲胆碱支气管激发试验标准技术规范(2023年)]
Zhonghua Jie He He Hu Xi Za Zhi. 2024 Feb 12;47(2):101-119. doi: 10.3760/cma.j.cn112147-20231019-00247.
6
Can child deaths be prevented? The Arizona Child Fatality Review Program experience.儿童死亡可以预防吗?亚利桑那州儿童死亡审查项目的经验。
Pediatrics. 2002 Jul;110(1 Pt 1):e11. doi: 10.1542/peds.110.1.e11.
7
A review of asthma care in 50 general practices in Bedfordshire, United Kingdom.英国贝德福德郡 50 家普通实践中哮喘护理的回顾。
NPJ Prim Care Respir Med. 2018 Jul 26;28(1):29. doi: 10.1038/s41533-018-0093-7.
8
An ongoing Confidential Enquiry into asthma deaths in the Eastern Region of the UK, 2001-2003.2001年至2003年对英国东部地区哮喘死亡情况进行的一项正在进行的保密调查。
Prim Care Respir J. 2005 Dec;14(6):303-13. doi: 10.1016/j.pcrj.2005.08.004. Epub 2005 Oct 11.
9
Preventing avoidable asthma deaths.预防可避免的哮喘死亡。
Practitioner. 2014 Sep;258(1774):27-31, 3.
10
Sepsis Care Pathway 2019.2019年脓毒症护理路径
Qatar Med J. 2019 Nov 7;2019(2):4. doi: 10.5339/qmj.2019.qccc.4. eCollection 2019.

引用本文的文献

1
Predictors of mortality and hospitalised exacerbations in obstructive airway diseases.阻塞性气道疾病死亡率及住院加重的预测因素
ERJ Open Res. 2025 Sep 8;11(5). doi: 10.1183/23120541.01276-2024. eCollection 2025 Sep.
2
Association between income, employment status, and asthma outcomes: a systematic review and meta-analysis.收入、就业状况与哮喘结局之间的关联:一项系统综述和荟萃分析。
Lancet Reg Health Eur. 2025 Jun 26;56:101367. doi: 10.1016/j.lanepe.2025.101367. eCollection 2025 Sep.
3
Adverse Outcomes Associated With Short-Acting Beta-Agonist Overuse in Asthma: A Systematic Review and Meta-Analysis.哮喘中短效β受体激动剂过度使用相关的不良结局:一项系统评价和荟萃分析。
Allergy. 2025 Jun;80(6):1629-1646. doi: 10.1111/all.16538. Epub 2025 Jun 10.
4
Psychosocial experience of living with severe and uncontrolled asthma as a young adult: a qualitative synthesis.青年成年人重度且未得到控制的哮喘患者的心理社会经历:一项定性综合研究
BMJ Open Respir Res. 2025 Mar 22;12(1):e002541. doi: 10.1136/bmjresp-2024-002541.
5
Health system characteristics and evidence-based asthma care.卫生系统特征与循证哮喘护理
Front Allergy. 2025 Feb 24;6:1528526. doi: 10.3389/falgy.2025.1528526. eCollection 2025.
6
Over-the-counter short-acting β-agonist purchase and asthma-related health outcomes: a post hoc analysis of the SABINA III study.非处方短效β-激动剂的购买与哮喘相关健康结局:SABINA III 研究的事后分析。
NPJ Prim Care Respir Med. 2024 Nov 1;34(1):34. doi: 10.1038/s41533-024-00397-4.
7
Economic burden of short-acting beta-2 agonist (SABA) overuse among asthma patients in Türkiye: a cost analysis with respect to the updated GINA treatment recommendations.土耳其哮喘患者中短效β2 激动剂(SABA)过度使用的经济负担:根据更新的 GINA 治疗建议进行的成本分析。
BMC Pulm Med. 2024 Oct 21;24(1):524. doi: 10.1186/s12890-024-03327-9.
8
A Review of the Latest Guidelines for Diagnosing and Managing Asthma in Children in the United States and Canada.美国和加拿大儿童哮喘诊断与管理最新指南综述
Cureus. 2024 Aug 29;16(8):e68135. doi: 10.7759/cureus.68135. eCollection 2024 Aug.
9
Treating severe paediatric asthma with mepolizumab or omalizumab: a protocol for the TREAT randomised non-inferiority trial.美泊利珠单抗或奥马珠单抗治疗严重儿童哮喘:TREAT 随机非劣效性试验方案。
BMJ Open. 2024 Aug 21;14(8):e090749. doi: 10.1136/bmjopen-2024-090749.
10
Uncovering patterns of inhaler technique and reliever use: the value of objective, personalized data from a digital inhaler.揭示吸入器技术和缓解药物使用模式:数字化吸入器提供客观、个性化数据的价值。
NPJ Prim Care Respir Med. 2024 Aug 20;34(1):23. doi: 10.1038/s41533-024-00382-x.

本文引用的文献

1
Death rates for asthma in English populations 1979-2007: comparison of underlying cause and all certified causes.1979-2007 年英国人群哮喘死亡率:根本死因与所有认证死因的比较。
Public Health. 2012 May;126(5):386-93. doi: 10.1016/j.puhe.2012.01.022. Epub 2012 Apr 18.
2
A guide to the translation of the Global Initiative for Asthma (GINA) strategy into improved care.《全球哮喘倡议(GINA)策略转化为改善护理的指南》
Eur Respir J. 2012 May;39(5):1220-9. doi: 10.1183/09031936.00184511. Epub 2012 Jan 26.
3
Risk factors for childhood asthma deaths from the UK Eastern Region Confidential Enquiry 2001-2006.英国东部地区2001 - 2006年儿童哮喘死亡的风险因素。
Prim Care Respir J. 2012 Mar;21(1):71-7. doi: 10.4104/pcrj.2011.00097.
4
Long-acting beta-agonists with and without inhaled corticosteroids and catastrophic asthma events.长效β-激动剂联合或不联合吸入性皮质类固醇与灾难性哮喘事件。
Am J Med. 2010 Apr;123(4):322-8.e2. doi: 10.1016/j.amjmed.2009.07.035. Epub 2010 Feb 20.
5
Reduction of asthma burden is possible through National Asthma Plans.通过国家哮喘计划,可以减轻哮喘负担。
Allergy. 2010 Apr;65(4):415-9. doi: 10.1111/j.1398-9995.2009.02265.x. Epub 2010 Jan 22.
6
An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice.美国胸科学会/欧洲呼吸学会官方声明:哮喘控制与加重:规范临床哮喘试验及临床实践的终点指标
Am J Respir Crit Care Med. 2009 Jul 1;180(1):59-99. doi: 10.1164/rccm.200801-060ST.
7
Interventions for educating children who are at risk of asthma-related emergency department attendance.针对有哮喘相关急诊就诊风险儿童的教育干预措施。
Cochrane Database Syst Rev. 2009 Apr 15;2009(2):CD001290. doi: 10.1002/14651858.CD001290.pub2.
8
A new perspective on concepts of asthma severity and control.哮喘严重程度与控制概念的新视角。
Eur Respir J. 2008 Sep;32(3):545-54. doi: 10.1183/09031936.00155307.
9
The UK General Practice Airways Group (GPIAG): its formation, development, and influence on the management of asthma and other respiratory diseases over the last twenty years.英国全科医疗 Airways 集团(GPIAG):其在过去二十年中的组建、发展及其对哮喘和其他呼吸系统疾病管理的影响。
Prim Care Respir J. 2007 Jun;16(3):132-9. doi: 10.3132/pcrj.2007.00042.
10
Asthma: 1987-2007. What have we achieved and what are the persisting challenges?哮喘:1987 - 2007年。我们取得了哪些成就,仍面临哪些挑战?
Prim Care Respir J. 2007 Jun;16(3):145-8. doi: 10.3132/pcrj.2007.00039.

全国哮喘死亡情况回顾:我们学到了什么,需要做出哪些改变?

The national review of asthma deaths: what did we learn and what needs to change?

作者信息

Levy Mark L

机构信息

Sessional general practitioner, London, UK.

出版信息

Breathe (Sheff). 2015 Mar;11(1):14-24. doi: 10.1183/20734735.008914.

DOI:10.1183/20734735.008914
PMID:26306100
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4487386/
Abstract

KEY POINTS

The 2014 UK National Review of Asthma Deaths identified potentially preventable factors in two-thirds of the medical records of cases scrutinised45% of people who died from asthma did not call for or receive medical assistance in their final fatal attackOverall asthma management, acute and chronic, in primary and secondary care was judged to be good in less than one-fifth of those who diedThere was a failure by doctors and nurses to identify and act on risk factors for asthma attacks and asthma deathThe rationale for diagnosing asthma was not evident in a considerable number of cases, and there were inaccuracies related to the completion of medical certificates of the cause of death in over half of the cases considered for the UK National Review of Asthma Deaths.

EDUCATIONAL AIMS

To increase awareness of some of the findings of the recent UK National Review of Asthma Deaths and previous similar studiesTo emphasise the need for accurate diagnosis of asthma, and of the requirements for completion of medical certificates of the cause of deathTo consider areas for improving asthma care and prevention of attacks and avoidable deaths.

SUMMARY

Despite the development and publication of evidence-based asthma guidelines nearly three decades ago, potentially preventable factors are repeatedly identified in studies of the care provided for patients who die from asthma. The UK National Review of Asthma Deaths (NRAD), a confidential enquiry, was no exception: major preventable factors were identified in two-thirds of asthma deaths. Most of these factors, such as inappropriate prescription and failure to provide patients with personal asthma action plans (PAAPs), could possibly have been prevented had asthma guidelines been implemented. NRAD involved in-depth scrutiny by clinicians of the asthma care for 276 people who were classified with asthma as the underlying cause of death in real-life. A striking finding was that a third of these patients did not actually die from asthma, and many had no recorded rationale for an asthma diagnosis. The apparent complacency with respect to asthma care, highlighted in NRAD, serves as a wake-up call for health professionals, patients and their carers to take asthma more seriously. Based on the NRAD evidence, the report made 19 recommendations for change. The author has selected six areas related to the NRAD findings for discussion and provides suggestions for change in the provision of asthma care. The six areas are: systems for provision and optimisation of asthma care, diagnosis, identifying risk, implementation of guidelines, improved patient education and self-management, and improved quality of completion of medical certificates of the cause of death.

摘要

关键点

2014年英国哮喘死亡病例全国审查发现,在三分之二经审查的病例医疗记录中存在潜在可预防因素。45%死于哮喘的人在其最终致命发作时未呼叫或未获得医疗救助。在不到五分之一的死亡病例中,初级和二级医疗保健机构对哮喘的整体管理(包括急性和慢性管理)被判定为良好。医生和护士未能识别哮喘发作和哮喘死亡的风险因素并采取相应行动。在相当多的病例中,哮喘诊断的基本原理并不明确,并且在英国哮喘死亡病例全国审查所考虑的一半以上病例中,与死亡原因医学证明的填写存在不准确之处。

教育目标

提高对近期英国哮喘死亡病例全国审查及以往类似研究的一些结果的认识。强调准确诊断哮喘以及填写死亡原因医学证明的要求。思考改善哮喘护理以及预防发作和避免可避免死亡的领域。

总结

尽管近三十年前就已制定并发布了基于证据的哮喘指南,但在对死于哮喘患者的护理研究中,仍反复发现潜在可预防因素。英国哮喘死亡病例全国审查(NRAD)是一项保密调查,也不例外:在三分之二的哮喘死亡病例中发现了主要可预防因素。如果实施哮喘指南,大多数这些因素,如处方不当和未为患者提供个人哮喘行动计划(PAAP),可能本可避免。NRAD涉及临床医生对276名在现实生活中被归类为以哮喘为根本死因的患者的哮喘护理进行深入审查。一个惊人的发现是,这些患者中有三分之一实际上并非死于哮喘,而且许多患者没有记录哮喘诊断的基本原理。NRAD中凸显的对哮喘护理明显的自满情绪,为卫生专业人员、患者及其护理人员敲响了警钟,提醒他们更严肃地对待哮喘。基于NRAD的证据,该报告提出了19项变革建议。作者选取了与NRAD结果相关的六个领域进行讨论,并为改善哮喘护理提供了变革建议。这六个领域是:哮喘护理的提供和优化系统、诊断、识别风险、指南的实施、改善患者教育和自我管理以及提高死亡原因医学证明的填写质量。